[SYRE] QoQ Quarter Result on 31-Mar-2019 [#Q1]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
31-Mar-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -15.23%
YoY- -111.44%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
Revenue 0 0 0 0 0 0 2,378 -
PBT -21,495 -21,573 -18,019 -17,167 -14,898 -11,917 -9,414 73.13%
Tax 0 0 0 0 0 0 0 -
NP -21,495 -21,573 -18,019 -17,167 -14,898 -11,917 -9,414 73.13%
Tax Rate - - - - - - - -
Total Cost 21,495 21,573 18,019 17,167 14,898 11,917 11,792 49.05%
Ratio Analysis
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 -395.88 -
Per Share
31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 30/09/18 30/06/18 CAGR
EPS 0.00 -16.40 -13.72 -14.79 0.00 -13.55 -11.43 -
EPS Diluted 0.00 -16.40 -13.72 -14.79 0.00 -13.55 -11.43 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.